2nd Announcement Fix-1
2nd Announcement Fix-1
2nd Announcement Fix-1
Welcome Remark
Assalamu’alaikum Wr. Wb
W e praise and thank Allah SWT for all His grace and guidance so that we can still
live and work well. With prayers and greetings, we praise His Majesty the Prophet
Muhammad SAW who has brought us to a world full of knowledge.
The National Congress of Indonesian Society of Endocrinology is a national event
of the Indonesian Society of Endocrinology (PERKENI). KONAS PERKENI is an effort to
improve services quality, medical knowledge and quality of education along with exchange
experiences and skills with Indonesian endocrine, metabolic and diabetes experts.
We, as hosts, are happy and proud to invite colleagues to attend The 13th National
Congress of the Indonesian Society of Endocrinology which will be held in Banda Aceh,
26-29 September 2024. But before that, the series of events would start on 20-22
September 2024, consisting of an online session symposium. The KONAS PERKENI raised
the theme “Update on Endocrinology, Metabolism and Diabetes in Facing the Challenges
of Indonesia’s Health Transformation”. Along with it, at this event, the 12th NATIONAL
ENDOCRINOLOGY FORUM (FEN) will also be held.
The Organizing Committee invites all participants to actively contribute to the
success of this great activity. This important meeting will be attended by all PERKENI
members in Indonesia.
Banda Aceh, a unique and Islamic city, hosts this event, presenting various
spectacular tours and culinary delights. Make sure you participate in this activity. Through
this Congress, it is hoped that we can increase our capacity and strengthen our role and
function, especially in improving health services in the field of Internal Medicine, especially
in the areas of endocrine, metabolic and diabetes.
We would like to express our thanks to all parties who supported the 13th National
Congress of the Indonesian Society of Endocrinology and we hope it will be useful in
improving health in Indonesia. Honoring guests with “pemulia jame” is the custom of the
Acehnese people. It is an honor for us to be able to welcome you all in 2024 in Banda
Aceh.
Wassalamu’alaikum Wr. Wb
Prof. Dr. dr. Ketut Suastika, SpPD, K-EMD, Dr. dr. Hendra Zufry, SpPD, K-EMD,
FINASIM FINASIM
2 KONAS Ke-13 PERKENI
Table of Content
Welcome Remark
Event Profile
Important Dates
Registration
KONAS Ke-13 PERKENI 3
Event Profile
Important Dates
Online Symposium
Day-1 (Friday, 20 September 2024)
Online Symposium
Day-3 (Sunday, 22 September 2024)
Workshop
Workshop Pre KONAS Ke-13 PERKENI
(Monday-Wednesday, 23-25 September 2024)
Hybrid Symposium
Day-1 (Friday, 27 September 2024)
Plenary Lecture 1
08.00-08.30
“An Efficient Clinic, Right Work in Right Time”
Plenary Lecture 2 (Menteri Kesehatan Republik Indonesia)
08.30-09.00 “Update on Endocrinology, Metabolism and Diabetes in Facing Challenges of
Indonesia’s Health Transformation”
09.00-09.40 Opening Ceremony
Symposium 30 Symposium 31
“40% of Men With Type 2 Diabetes “Lipids – From Statins to PCSK9i and
16.00-17.00 Have Symptomatic Testosterone Beyond”
Deficiency – Why are We Still Not
Finding and Treating These Men?”
19.30-20.00 Dinner
Symposium 32
20.00-21.00 “SGLT2i: Recent Advances in Clinical Evidence and Molecular Mechanism of Anti-
Diabetic Therapy and Heart Failure”
21.00-22.00 Entertainment
KONAS Ke-13 PERKENI 9
Hybrid Symposium
Day-2 (Saturday, 28 September 2024)
Plenary Lecture 3
08.00-08.30 “Effects of FDC Ezetimibe and Rosuvastatin for High-Risk Patients
with Atherosclerosis Prone with Hypercholesterolemia”
Symposium 33 Symposium 34
“The role of GLP-1 Analogs and “Optimal glycaemic control with
08.30-09.30 DPP-4 Inhibitors in Type 2 self-monitoring of blood glucose
Diabetes Therapy: Review of in type 2 diabetes”
Head-to-Head Clinical Trials”
Symposium 35 Symposium 36
“Initiating or Switching to Insulin “Sulphonylureas in the current
Degludec/Insulin Aspart in management of type 2 diabetes:
09.30-10.30 Adults with Type 2 Diabetes: A is still worth it?”
Real-World Non-interventional
Study”
Symposium 37 Symposium 38
“Empagliflozin-Linagliptin: A “The fundamental problem of
10.30-11.30 Dual-Acting Oral Medication insulin resistance in type 2
Approved for the Treatment of diabetes mellitus: Target therapy
Patients with Type 2 Diabetes” of Thiazolidinediones (TZDs)”
Symposium 39 Symposium 40
“Usual and not so usual cases “Effect of Dapagliflozin in DAPA-
11.30-12.30 with insulin in type 2 diabetes: HF According to Background
what do you recommend?” Glucose-Lowering Therapy”
Organizational Meeting
PEDI & PERSADIA (Thursday, 26 September 2024)
1) STRUCTURE
• Title: Maximum of 120 characters (including space).
• Author: The number of authors is not limited.
• Contents
1. Case report consists of background, case illustration, discussion, conclusion, and
references.
2. Original article and literature review consist of background, objective, method, result,
discussion, conclusion, and references.
• Word count: Maximum of 250 words (for the whole abstract).
• Language: English
2) SUBMISSION GUIDELINE
• Abstract submission is open online until 31 Augustus 2024 (GMT +8) at
[email protected]
• 13th KONAS PERKENI 2024 accepts Instruction Free Paper, E-poster and Video submission.
• All abstracts must be submitted in English exclusively via the online abstract submission
system. Submissions by post, email, fax or any other means will NOT be accepted.
• AUTHORS – FIRST (PRESENTING) AUTHOR – The first author will be the presenting
author. The first (presenting) author is expected to register and pay the full registration
fee, attend the Congress and make the presentation.
• Please provide an accurate email address and handphone number for the first (presenting)
author. Abstract submission results and abstract-related correspondence will be sent by
email to the first author.
• Authors can submit a maximum of 5 abstracts and they can serve as the first author of
3 submitted abstracts at most. Among the 3 abstracts, they can present a maximum of 2
abstracts that are of the same presentation type.
• CO-AUTHOR(S) – A maximum of five co-authors are allowed for each abstract. Type in
the names and affiliations as you would like them to appear in any publications. Please
give the names in full for each of the co-authors. Initials are only accepted for middle
12 KONAS Ke-13 PERKENI
3) SUBMISSION TIMELINE
5) CHECKLIST
Before submission, please check:
• If the abstract has a concise, descriptive title;
• If the study has sufficient data leading to conclusive outcomes;
• If the abstract states clearly the purpose, methods, results and conclusions of the study;
• If the study is conducted in a methodologically correct way;
• If the abstract is proofread and/or edited by a native speaker of English;
• If the abstract is within the word limit;
• If financial disclosures for each of the authors are made.
6) ONLINE SUBMISSION
Submit your abstract now via the 13th KONAS PERKENI 2024 Congress system.
Other Activities
Public Seminar
• 26 September 2024
• The participants are civil society
• Presenters from PERKENI
• Venue: Anjong Mon Mata Pendopo
Gubernur Aceh
5K Run
&
Mass Diabetes Gymnastics
• 29 September 2024
• The participants are civil society
• Location: Blang Padang Field
KONAS Ke-13 PERKENI 15
• 29 September 2024
• All participants of The 13th KONAS PERKENI
• Takengon Plateau (optional)
16 KONAS Ke-13 PERKENI
CGK-BTJ BTJ-CGK
No Airline*
ETD ETA ETD ETA
(WIB) (WIB) (WIB) (WIB)
Flight Information
KUL-BTJ BTJ-KUL
No Airline*
ETD ETA ETD ETA
(WIB) (WIB) (WIB) (WIB)
PEN-BTJ BTJ-PEN
No Airline*
ETD ETA ETD ETA
(WIB) (WIB) (WIB) (WIB)
Registration
Medical
Specialist/ Resident/ Student &
No Registration Fee
Fellow GP Health
Practitioner
Registration
Please visit this address or click link below:
https://konas.pbperkeni.or.id
Payment Information
Bank Mandiri Capem RSCM
Account Number : 122-00-0778828-7
A/n : PB PERKENI
Address : Jalan Diponegoro 71 Jakarta
Committee
Phone/WhatsApp : +62 812 1533 0621 (dr. Alisa Andalia)
E-mail : [email protected]
20 KONAS Ke-13 PERKENI
Contact Information
Registration
dr. Alisa Andalia (+62 812 1533 0621)
[email protected]
Abstract Submission
dr. Azizah Dhena Harca (+62 813 5098 6979)
[email protected]
Scientific
dr. Nur Arfah Riski (+62 821 6208 9691)
[email protected]
Secretariat:
Division of Endocrinology, Metabolism & Diabetes – Thyroid Center,
Department of Internal Medicine, School of Medicine,
Syiah Kuala University / Dr. Zainoel Abidin General Teaching Hospital,
Jl. Tgk. Daud Beureueh No. 108
Banda Aceh- Indonesia